What happens when you take choline with inositol?
Choline and inositol are two B-vitamin-adjacent compounds that have been grouped together in 'lipotropic' formulas since the 1940s, because both promote the mobilization and export of fat out of the liver. Choline is the precursor to phosphatidylcholine, which is the main phospholipid in the outer coat of very-low-density lipoprotein (VLDL) particles. Without enough choline, the liver cannot package newly-made triglycerides into VLDL for export to peripheral tissues, and fat begins to accumulate inside hepatocytes - the same process that drives non-alcoholic fatty liver disease.
Inositol (most commonly myo-inositol, sometimes D-chiro-inositol) is the structural backbone of phosphatidylinositol, another major membrane phospholipid, and of the inositol phosphate second-messenger system that mediates insulin signaling. A 2020 systematic review in Nutrients (PMC7694137) examined 11 studies on inositol and NAFLD and found that inositol deficiency was associated with increased hepatic triglyceride accumulation in animal models, while supplementation with myo-inositol or pinitol reduced liver fat and improved transaminases. Combined administration of choline and inositol therefore covers two complementary lipid-handling pathways simultaneously.
Why is this important?
Choline deficiency is surprisingly common. The 2020 US Dietary Guidelines note that more than 90% of Americans fail to meet the Adequate Intake for choline (550 mg/day for men, 425 mg/day for women), largely because the richest source - egg yolk - has been displaced by lower-yolk diets. People on plant-based diets and women in pregnancy or breastfeeding are at particular risk. A PMC review (Choline's Role in Maintaining Liver Function, PMC3729018) details how inadequate choline drives a cascade from simple fatty liver toward fibrosis and ultimately hepatocellular carcinoma in animal models.
Inositol has a parallel story. Myo-inositol is well-studied in polycystic ovary syndrome (PCOS), where it improves ovulation, insulin sensitivity, and lipid profiles. Because PCOS is strongly associated with NAFLD, the two conditions often coexist, and the choline-inositol combination addresses both the metabolic insulin-resistance side (inositol) and the lipid-export side (choline). UK clinical guidance (NICE) does not currently recommend choline-inositol as a first-line NAFLD treatment - lifestyle modification remains primary - but the supportive role is well-grounded in biochemistry.
What should you do?
A common daily stack is 500-1,000 mg choline (as choline bitartrate, alpha-GPC, CDP-choline/citicoline, or 1,200-2,400 mg of phosphatidylcholine from soy/sunflower lecithin) combined with 1,000-2,000 mg of inositol, taken with food. Women with PCOS often use 2 g myo-inositol twice a day. Higher choline doses (above 3 g/day) can cause a fishy body odor due to trimethylamine production by gut bacteria - if this happens, switch to alpha-GPC or CDP-choline, which produce less odor.
Don't bother with the old 'lipotropic injection' shots from weight-loss clinics unless you have a confirmed deficiency; oral choline and inositol are well-absorbed at standard doses. If you eat 2-3 whole eggs per day, you may already be getting 250-300 mg of choline from food, so adjust the supplement accordingly. Pair with a Mediterranean-style diet and weight loss for additive benefit in fatty liver.
Which specific products are affected?
Classic 'choline & inositol' combinations are sold by Solgar, Nature's Plus and NOW Foods, typically as 500/500 mg per capsule. PCOS-targeted formulas (Theralogix Ovasitol, Wholesome Story Myo-Inositol & D-Chiro) focus on the inositol component. Liver-support formulas (Pure Encapsulations Liver-G.I. Detox, Designs for Health LV-GB Complex) include both alongside milk thistle, NAC and alpha-lipoic acid. Lecithin granules (soy or sunflower) provide phosphatidylcholine plus a small amount of inositol naturally and are a food-based alternative.
The bottom line
Choline and inositol are a long-standing, low-risk pairing that supports liver fat export and lipid metabolism. The evidence base is strongest in animal models of fatty liver and in women with PCOS, with growing human data in NAFLD. They are not a substitute for diet and exercise in fatty liver, but they are a sensible adjunct, particularly for people whose diets are low in eggs or who are pregnant, breastfeeding, or on TPN.